Cochlear is the world leader in cochlear implants, the breakthrough technology that has enabled tens of thousands of severe to profoundly hearing impaired people to hear. The company was founded on the unique work of Australian Professor Dr. Graeme Clark, the founder of the multi-channel cochlear implant. Today Cochlear is a publicly listed company on the Australian Stock Exchange.

For over 25 years Cochlear has lead the industry in product safety, reliability and technological innovation. Today Cochlear supports over 60,000 Nucleus recipients and offers it's Cochlear Implant system in more than 70 countries around the world. Cochlear continues to lead the way in innovation. Its research program is extensive with the company participating in more than 90 collaborative research programs with university and research hospitals in more than 35 countries. Cochlear research efforts are closely linked to those of the Bionic Ear Institute, University of Melbourne and the Cooperative Research Centre for Cochlear Implants and Hearing Innovation.

In 2005 Cochlear announced the release of the Nucleus?Freedom?system, which is the world's first water resistant cochlear implant system. Furthering their commitment and dedication to hearing, Cochlear announced it's acquisition of Entific Medical, the manufacture of the Baha in April 2005.

If you would like to find out more about Cochlear, please visit www.cochlear.com.